
27th Annual Meeting and Symposium of the
Desert Tortoise Council, March 22-24, 2002 Abstracts

Health Assessments of Captive and Wild Desert Tortoises at 17
Sites in the Mojave and Colorado Deserts, California
Kristin H. Berry, Ph.D.1, Tracy Okamoto2,
Kemp Anderson3, Mary B. Brown, M.S., Ph.D.4;
Lori Wendland, DVM4; and Francesco Origgi, DVM, Ph.D5
1U. S. Geological Survey, 6221 Box Springs Blvd.,
Riverside, CA 92507;
2Inyokern, CA 93527;
3Long Beach, CA90803-4047;
4Department of Pathobiology, College of Veterinary Medicine,
University of Florida, Gainesville, FL;
5Human Virology Unit, Department of Infectious Diseases and
Immunology, San Raffaele Scientific Institute (Dibit), Via Olgettina
58, 20132 Milano, Italy

Between 1998 and 2001 we conducted in-depth health assessments of
captive desert tortoises (Gopherus agassizii) at 2 desert towns
and of wild desert tortoises at 15 field sites in the Mojave and
Colorado deserts of California. Health assessments included collecting
data on detailed clinical signs of health and disease, e.g., recording
signs of upper respiratory tract disease (URTD), shell disease, and
trauma; and taking blood and/or lymph samples and nasal lavages for
laboratory analysis. The field health assessments were followed by
analysis of tissue samples using enzyme-linked immunoassay (ELISA) and
polymerase chain reaction (PCR) tests and cultures for Mycoplasma
at the University of Florida. Some populations were tested for the
herpesvirus using the new ELISA test developed by Dr. Origgi and others.
Using a combination of laboratory tests, 61.8% of captive tortoises
from Ridgecrest and Inyokern (N = 34) and 60% of captive tortoises from
Joshua Tree, Twentynine Palms, and Palm Springs (N = 30) tested positive
for Mycoplasma agassizii and/or M. "mysteriosa".
Most tortoises with positive clinical tests also showed multiple,
moderate to severe clinical signs of URTD. The group of captive
tortoises from the Joshua Tree, Twentynine Palms, and Palm Springs areas
was also tested for herpesvirus and 32.1% had positive tests. Of the
tortoises that tested positive for antibody to herpesvirus, 44.4% had
concomitant positive tests for mycoplasma. In general, captive tortoises
kept isolated from other captive tortoises and with a history of only
one owner tested negative for mycoplasmosis and the herpesvirus.
Between 1997 and 1999, 142 samples were collected from 13 wild desert
tortoises at seven plots (Tiefort, Alvord 6, Langford, Eastgate 1,
Eastgate 2, Goldstone 12, Goldstone 15) within Ft. Irwin in the central
Mojave Desert for URTD tests. Only one Goldstone plot produced positive
samples (2 of 5 tortoises tested for both ELISA and cultures). Between
2000-2001, 121 samples were taken from 119 wild tortoises at 9 study
plots from the western Mojave, central Mojave, northeastern Mojave,
eastern Mojave, and northern Colorado deserts. Sites and sample sizes
were Fremont Valley (N = 9), Ft. Irwin-Control (N = 20), Ft. Irwin-Tiefort
(N = 17), Marine Corps Air Ground Combat Center (MCAGCC)-Sandhill (N =
25), Ord-Rodman (N = 12), Superior Cronese (N = 6), Ivanpah Valley (N =
16), Goffs (N = 6), and Ward Valley (N = 10). Samples were not
necessarily available for all the tortoises for all the different URTD
tests. None of the 119 tortoises tested positive for Mycoplasma
agassizii and/or M. "mysteriosa." However,
of 66 tortoises tested for herpesvirus, 6 (9%) were positive: 3 at
MCAGCC-Sandhill, 2 at Ord-Rodman, and 1 at Ivanpah Valley. The sites
where animals tested positive for herpesvirus were sites with higher
sample sizes (N > 12). Twenty G0 tortoises (see Medica et
al., these abstracts) from the line-distance sampling projects at
MCAGCC-Sandhill, Ord-Rodman, and Super-Cronese were tested for
herpesvirus; of the 20, 4 (20%) tested positive.
Overall the percentages of captive tortoises with positive tests for
one or more infectious diseases were considerably higher than
percentages observed in the samples from most wild populations, a
pattern reported by April Johnson et al. at this meeting and
others in the literature. We recommend continued and more intensive
sampling of desert tortoises for clinical signs of all significant
diseases. We think all tortoises in research and monitoring programs
should be tested using the available ELISA and PCR tests and cultures,
and records should be kept and analyzed on patterns of clinical signs of
disease. We recommend educating owners of captive tortoises about
infectious diseases and providing protocols for quarantining individuals
and segregating different species.
Acknowledgments: Financial support was provided by the U. S.
Geological Survey, National Training Center at Ft. Irwin, and Marine Air
Ground Task Force Training Command at Twentynine Palms. Thanks are due
to Rhys Evans, Peter Woodman, Paul Frank, Rachel Woodard, and Taylor
Edwards for field and clinical support.
|